Centene Corp (CNC) Stock AnalysisCNCStock AnalysisCentene Corp

Centene Corporation is a healthcare company. It provides access to quality healthcare; programs and a range of health solutions that help families and individuals get well. Its segments include Medicaid, Medicare, Commercial and Other. The Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

Centene Corp is a good buy right now due to its current price of $64.75, which is below the average analyst price target of $76.75. The company has shown a year-to-date change of +54.98%, indicating strong momentum. However, the RSI is at 44.77, suggesting it is not overbought, which presents a favorable entry point. The main risk is the negative net income reported in 2025, with a loss of $6.63 per share, which could affect investor sentiment if not addressed.

17 analysts cover CNC: 12 rate it Buy, 5 Hold and 0 Sell. The average price target is 43.07.